Sanitar Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,595	2,601	2,770	2,481	2,652	2,358
Other Revenue	17.98	17.47	20.2	19.59	17.44	14.98
Revenue	2,613	2,618	2,790	2,501	2,670	2,373
Revenue Growth (YoY)	-7.72%	-6.17%	11.58%	-6.32%	12.52%	2.87%
Cost of Revenue	1,630	1,654	1,801	1,643	1,750	1,575
Gross Profit	983.09	964.13	989.48	857.62	919.34	797.55
Selling, General & Admin	580.06	573	575.77	535.16	518.69	483.14
Research & Development	32.51	34.02	37.89	35.19	28.61	22.83
Other Operating Expenses	-42.59	-	-	-	-	0.11
Operating Expenses	569.98	607.02	616.96	569.01	546.72	510.32
Operating Income	413.11	357.11	372.52	288.61	372.63	287.23
Interest Expense	-5.2	-5.09	-5.11	-5.88	-7.72	-7.07
Interest & Investment Income	16.64	15.44	10.67	7.56	4.35	3.73
Currency Exchange Gain (Loss)	7.84	7.84	15.53	8.86	9.82	3.97
Other Non Operating Income (Expenses)	-0.13	0.8	0.89	2.9	1.47	2.11
EBT Excluding Unusual Items	432.27	376.1	394.51	302.04	380.54	289.97
Gain (Loss) on Sale of Investments	0.57	0.57	12.87	4.6	2.5	-3.18
Gain (Loss) on Sale of Assets	10.1	10.1	1.01	1.62	0.39	0.92
Asset Writedown	-32.45	-32.45	-	-	-	-
Other Unusual Items	-	-	0.17	-	-	-
Pretax Income	410.49	354.32	408.55	308.26	383.43	287.71
Income Tax Expense	104.13	90.84	87.44	70.8	88.14	62.86
Earnings From Continuing Operations	306.36	263.48	321.11	237.46	295.29	224.85
Minority Interest in Earnings	-1.87	-1.27	-5.88	-1.82	-4.46	-3.48
Net Income	304.48	262.21	315.23	235.64	290.83	221.37
Net Income to Common	304.48	262.21	315.23	235.64	290.83	221.37
Net Income Growth	3.65%	-16.82%	33.78%	-18.98%	31.38%	0.58%
Shares Outstanding (Basic)	76	73	72	72	72	72
Shares Outstanding (Diluted)	77	73	73	73	73	72
Shares Change (YoY)	5.56%	0.48%	0.27%	-0.06%	0.35%	-0.43%
EPS (Basic)	3.99	3.61	4.37	3.27	4.04	3.07
EPS (Diluted)	3.97	3.59	4.33	3.25	4.01	3.06
EPS Growth	-1.54%	-17.09%	33.23%	-18.95%	31.05%	0.99%
Free Cash Flow	447.3	423.98	252.18	303.25	334.37	216.22
Free Cash Flow Per Share	5.82	5.80	3.47	4.18	4.61	2.99
Dividend Per Share	2.200	2.200	2.400	1.800	2.300	2.000
Dividend Growth	-8.33%	-8.33%	33.33%	-21.74%	15.00%	-
Gross Margin	37.62%	36.82%	35.46%	34.29%	34.44%	33.62%
Operating Margin	15.81%	13.64%	13.35%	11.54%	13.96%	12.11%
Profit Margin	11.65%	10.02%	11.30%	9.42%	10.89%	9.33%
Free Cash Flow Margin	17.12%	16.19%	9.04%	12.13%	12.53%	9.11%
EBITDA	484.39	430.03	455.6	375.22	462.99	375.72
EBITDA Margin	18.54%	16.42%	16.33%	15.00%	17.34%	15.84%
D&A For EBITDA	71.28	72.92	83.07	86.61	90.37	88.5
EBIT	413.11	357.11	372.52	288.61	372.63	287.23
EBIT Margin	15.81%	13.64%	13.35%	11.54%	13.96%	12.11%
Effective Tax Rate	25.37%	25.64%	21.40%	22.97%	22.99%	21.85%
Revenue as Reported	2,613	2,618	2,790	2,501	2,670	2,373